New advances in ANU anti-cancer drug research

被引：0
|
作者：
不详
机构：
来源：
AUSTRALASIAN BIOTECHNOLOGY | 1999年 / 9卷 / 03期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：142 / 143
页数：2
相关论文
共 50 条
  • [31] Recent advances in the field of anti-cancer immunotherapy
    Neves, Henrique
    Kwok, Hang Fai
    [J]. BBA CLINICAL, 2015, 3 : 280 - 288
  • [32] Recent advances in clinical anti-cancer immunotherapy
    Juretic, Antonio
    [J]. PERIODICUM BIOLOGORUM, 2014, 116 (04) : 365 - 370
  • [33] Advances in oral delivery of anti-cancer prodrugs
    Jain, Amit K.
    Jain, Sanyog
    [J]. EXPERT OPINION ON DRUG DELIVERY, 2016, 13 (12) : 1759 - 1775
  • [34] Valproic acid as anti-cancer drug
    Michaelis, Martin
    Doerr, Hans Wilhelm
    Cinatl, Jindrich, Jr.
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2007, 13 (33) : 3378 - 3393
  • [35] Anti-Cancer Drug Delivery System
    Li Yan
    Huang Wei
    Huang Ping
    Zhu Xinyuan
    Yan Deyue
    [J]. PROGRESS IN CHEMISTRY, 2014, 26 (08) : 1395 - 1408
  • [36] Mitosis as an anti-cancer drug target
    Anna-Leena Salmela
    Marko J. Kallio
    [J]. Chromosoma, 2013, 122 : 431 - 449
  • [37] MACROMOLECULE ANTI-CANCER DRUG CONJUGATES
    KATO, Y
    HARA, T
    [J]. JOURNAL OF SYNTHETIC ORGANIC CHEMISTRY JAPAN, 1983, 41 (12) : 1135 - 1142
  • [38] Mitosis as an anti-cancer drug target
    Salmela, Anna-Leena
    Kallio, Marko J.
    [J]. CHROMOSOMA, 2013, 122 (05) : 431 - 449
  • [39] Optimal Anti-cancer Drug Profiles for Effective Penetration of the Anti-cancer Drug Market by Generic Drugs in Japan
    Shoyo Shibata
    Maiko Matsushita
    Yoshimasa Saito
    Takeshi Suzuki
    [J]. Therapeutic Innovation & Regulatory Science, 2018, 52 : 442 - 448
  • [40] Optimal Anti-cancer Drug Profiles for Effective Penetration of the Anti-cancer Drug Market by Generic Drugs in Japan
    Shibata, Shoyo
    Matsushita, Maiko
    Saito, Yoshimasa
    Suzuki, Takeshi
    [J]. THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2018, 52 (04) : 442 - 448
12345